Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to show that the intake of L-citrulline improves muscle function in patients with Post-Polio Syndrome (PPS).


Clinical Trial Description

This is a single center, randomized, double-blind, placebo controlled study. The study medication consists of L-citrulline, respectively placebo given orally; 5 g L-citrulline or placebo will be given three times daily. The duration of the study is 48 weeks and comprehends one screening and four study visits.

Additionally, in order to investigate whether PPS is associated with an atrophy of spinal cord gray and potentially also white matter as well as motor cortex atrophy, it is planned to offer all trial participants an additional optional spinal cord/brain MRI investigation and a MRI at week 48 and a follow-up one year later together with a clinical and physiotherapy assessment during extension phase. We don't expect Citrulline to affect the spinal cord gray or white and gray matter. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02801071
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase Phase 3
Start date June 14, 2016
Completion date October 5, 2018

See also
  Status Clinical Trial Phase
Terminated NCT02176863 - Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome Phase 2/Phase 3
Active, not recruiting NCT03561623 - Spinal Cord Gray Matter Imaging in Post Polio Syndrome
Completed NCT02815878 - Enhance Wellness for Individuals With Long-Term Physical Disabilities N/A
Recruiting NCT05644522 - Nomad P-KAFO Study N/A
Completed NCT03064711 - Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics in Post-Polio Patients N/A
Completed NCT01537575 - Intravenous Immunoglobulins for Post-Polio Syndrome Phase 3
Active, not recruiting NCT02089880 - Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis N/A
Completed NCT01402570 - Glutathione and Health With Post-Polio Syndrome N/A
Completed NCT00231439 - Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) Phase 2/Phase 3